These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 18483187

  • 1. Whole-tumor perfusion CT parameters and glucose metabolism measurements in head and neck squamous cell carcinomas: a pilot study using combined positron-emission tomography/CT imaging.
    Bisdas S, Spicer K, Rumboldt Z.
    AJNR Am J Neuroradiol; 2008 Aug; 29(7):1376-81. PubMed ID: 18483187
    [Abstract] [Full Text] [Related]

  • 2. Outcome prediction after surgery and chemoradiation of squamous cell carcinoma in the oral cavity, oropharynx, and hypopharynx: use of baseline perfusion CT microcirculatory parameters vs. tumor volume.
    Bisdas S, Nguyen SA, Anand SK, Glavina G, Day T, Rumboldt Z.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1313-8. PubMed ID: 18963541
    [Abstract] [Full Text] [Related]

  • 3. Pilot study of combined FDG-PET and dynamic contrast-enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response.
    Banks TI, von Eyben R, Hristov D, Kidd EA.
    Cancer Med; 2018 Aug 01; 7(8):3642-3651. PubMed ID: 29963760
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
    Anderson CM, Chang T, Graham MM, Marquardt MD, Button A, Smith BJ, Menda Y, Sun W, Pagedar NA, Buatti JM.
    Int J Radiat Oncol Biol Phys; 2015 Mar 01; 91(3):472-9. PubMed ID: 25680593
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical usefulness of dual-time FDG PET-CT in assessment of esophageal squamous cell carcinoma.
    Shum WY, Hsieh TC, Yeh JJ, Chen JH, Su CC, Liang JA, Kao CH.
    Eur J Radiol; 2012 May 01; 81(5):1024-8. PubMed ID: 21458941
    [Abstract] [Full Text] [Related]

  • 9. Is there a correlation between 18F-FDG-PET standardized uptake value, T-classification, histological grading and the anatomic subsites in newly diagnosed squamous cell carcinoma of the head and neck?
    Haerle SK, Huber GF, Hany TF, Ahmad N, Schmid DT.
    Eur Arch Otorhinolaryngol; 2010 Oct 01; 267(10):1635-40. PubMed ID: 20680640
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. PET measured hypoxia and MRI parameters in re-irradiated head and neck squamous cell carcinomas: findings of a prospective pilot study.
    Rogasch J, Beck M, Stromberger C, Hofheinz F, Ghadjar P, Wust P, Budach V, Amthauer H, Tinhofer I, Furth C, Walter-Rittel TC, Zschaeck S.
    F1000Res; 2020 Oct 01; 9():1350. PubMed ID: 33796277
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
    Huang YE, Chen CF, Huang YJ, Konda SD, Appelbaum DE, Pu Y.
    Acta Radiol; 2010 Sep 01; 51(7):782-8. PubMed ID: 20707663
    [Abstract] [Full Text] [Related]

  • 16. Computed tomography perfusion of squamous cell carcinoma of the upper aerodigestive tract. Initial results.
    Gandhi D, Hoeffner EG, Carlos RC, Case I, Mukherji SK.
    J Comput Assist Tomogr; 2003 Sep 01; 27(5):687-93. PubMed ID: 14501359
    [Abstract] [Full Text] [Related]

  • 17. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
    Higgins KA, Hoang JK, Roach MC, Chino J, Yoo DS, Turkington TG, Brizel DM.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):548-53. PubMed ID: 21277108
    [Abstract] [Full Text] [Related]

  • 18. 18F-FDG-PET/CT parameters as imaging biomarkers in oral cavity squamous cell carcinoma, is visual analysis of PET and contrast enhanced CT better than the numbers?
    Kendi AT, Corey A, Magliocca KR, Nickleach DC, Galt J, Switchenko JM, El-Deiry MW, Wadsworth JT, Hudgins PA, Saba NF, Schuster DM.
    Eur J Radiol; 2015 Jun 01; 84(6):1171-6. PubMed ID: 25816993
    [Abstract] [Full Text] [Related]

  • 19. Preliminary assessment of dynamic contrast-enhanced CT implementation in pretreatment FDG-PET/CT for outcome prediction in head and neck tumors.
    Abramyuk A, Wolf G, Shakirin G, Haberland U, Tokalov S, Koch A, Appold S, Zöphel K, Abolmaali N.
    Acta Radiol; 2010 Sep 01; 51(7):793-9. PubMed ID: 20583948
    [Abstract] [Full Text] [Related]

  • 20. An exploratory pilot study into the association between microcirculatory parameters derived by MRI-based pharmacokinetic analysis and glucose utilization estimated by PET-CT imaging in head and neck cancer.
    Bisdas S, Seitz O, Middendorp M, Chambron-Pinho N, Bisdas T, Vogl TJ, Hammerstingl R, Ernemann U, Mack MG.
    Eur Radiol; 2010 Oct 01; 20(10):2358-66. PubMed ID: 20443116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.